| 789898 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models |
2022-01-01 |
10.1136/jitc-2021-003368 |
Koch Marilin S, Zdioruk Mykola, Nowicki Michal O, Griffith Alec M, Aguilar Estuardo, Aguilar Laura K, Guzik Brian W, Barone Francesca, Tak Paul P, Tabatabai Ghazaleh, Lederer James A, Chiocca E Antonio, Lawler Sean |
| 789897 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
B cells imprint adoptively transferred CD8+ T cells with enhanced tumor immunity |
2022-01-01 |
10.1136/jitc-2021-003078 |
Smith Aubrey S, Knochelmann Hannah M, Wyatt Megan M, Rangel Rivera Guillermo O, Rivera-Reyes Amalia M, Dwyer Connor J, Ware Michael B, Cole Anna C, Neskey David M, Rubinstein Mark P, Liu Bei, Thaxton Jessica E, Bartee Eric, Paulos Chrystal M |
| 789896 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature |
2022-01-01 |
10.1136/jitc-2021-003687 |
Bertucci Francois, Niziers Vincent, de Nonneville Alexandre, Finetti Pascal, Mescam Léna, Mir Olivier, Italiano Antoine, Le Cesne Axel, Blay Jean-Yves, Ceccarelli Michele, Bedognetti Davide, Birnbaum Daniel, Mamessier Emilie |
| 789895 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Intratumor expanded T cell clones can be non-sentinel lymph node derived in breast cancer revealed by single-cell immune profiling |
2022-01-01 |
10.1136/jitc-2021-003325 |
Jiao Shiping, Xiong Qing, Yan Meisi, Zhan Xiaolu, Yang Zhenhuang, Peng Cheng, Sun Beicheng, Pang Da, Liu Tong |
| 789894 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Safety and efficacy of dendritic cell-based immunotherapy DCVAC/OvCa added to first-line chemotherapy (carboplatin plus paclitaxel) for epithelial ovarian cancer: a phase 2, open-label, multicenter, randomized trial |
2022-01-01 |
10.1136/jitc-2021-003190 |
Rob Lukas, Cibula David, Knapp Pawel, Mallmann Peter, Klat Jaroslav, Minar Lubos, Bartos Pavel, Chovanec Josef, Valha Petr, Pluta Marek, Novotny Zdenek, Spacek Jiri, Melichar Bohuslav, Kieszko Dariusz, Fucikova Jitka, Hrnciarova Tereza, Korolkiewicz Roman Pawel, Hraska Marek, Bartunkova Jirina, Spisek Radek |
| 789893 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Safety and tolerability of andecaliximab as monotherapy and in combination with an anti-PD-1 antibody in Japanese patients with gastric or gastroesophageal junction adenocarcinoma: a phase 1b study |
2022-01-01 |
10.1136/jitc-2021-003518 |
Yoshikawa Akie Kimura, Yamaguchi Kensei, Muro Kei, Takashima Atsuo, Ichimura Takashi, Sakai Daisuke, Kadowaki Shigenori, Chin Keisho, Kudo Toshihiro, Mitani Seiichiro, Kitano Shigehisa, Thai Dung, Zavodovskaya Marianna, Liu JieJane, Boku Narikazu, Satoh Taroh |
| 789892 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Single-center experience using anakinra for steroid-refractory immune effector cell-associated neurotoxicity syndrome (ICANS) |
2022-01-01 |
10.1136/jitc-2021-003847 |
Wehrli Marc, Gallagher Kathleen, Chen Yi-Bin, Leick Mark B, McAfee Steven L, El-Jawahri Areej R, DeFilipp Zachariah, Horick Nora, O'Donnell Paul, Spitzer Thomas, Dey Bimal, Cook Daniella, Trailor Michael, Lindell Kevin, Maus Marcela V, Frigault Matthew J |
| 789891 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Hepatic stellate cell activation and senescence induced by intrahepatic microbiota disturbances drive progression of liver cirrhosis toward hepatocellular carcinoma |
2022-01-01 |
10.1136/jitc-2021-003069 |
Liu Boyuan, Zhou Zewei, Jin Yu, Lu Jinying, Feng Dongju, Peng Rui, Sun Hua, Mu Xiaoxin, Li Changxian, Chen Yun |
| 789890 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Role of Fcγ receptors in HER2-targeted breast cancer therapy |
2022-01-01 |
10.1136/jitc-2021-003171 |
Musolino Antonino, Gradishar William J, Rugo Hope S, Nordstrom Jeffrey L, Rock Edwin P, Arnaldez Fernanda, Pegram Mark D |
| 789889 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Antitumor activity and safety of camrelizumab plus famitinib in patients with platinum-resistant recurrent ovarian cancer: results from an open-label, multicenter phase 2 basket study |
2022-01-01 |
10.1136/jitc-2021-003831 |
Xia Lingfang, Peng Jin, Lou Ge, Pan Mei, Zhou Qi, Hu Wenjing, Shi Huirong, Wang Li, Gao Yunong, Zhu Jianqing, Zhang Yu, Sun Rong, Zhou Xianfeng, Wang Quanren, Wu Xiaohua |
